With the surge in popularity of GLP-1 RAs for weight loss and diabetes management, this study aims to enhance patient understanding and informed decision-making regarding these medications, countering trends driven by celebrity endorsements and promoting better healthcare outcomes. The gene discussed is GLP1R; the disease is diabetes mellitus.